Factor | Steroid-induced ONFH (+) Cases (N = 94) | Steroid-induced ONFH (-) Cases (N = 106) | P |
---|---|---|---|
Gender | |||
Male | 40 | 64 | 0.02 |
Female | 54 | 42 | |
Age (year) | |||
Median (Range) | 38.00 (18–82) | 44.50 (18–80) | 0.23 |
Mean | 40.22 ± 14.78 | 43.09 ± 18.36 | |
Body mass index (BMI, Kg/m 2 ) | |||
Median (Range) | 22.8 (16.9-30.8) | 24.45 (18.48-30.12) | <0.001 |
Mean | 23.01 ± 3.00 | 24.36 ± 2.42 | |
Concurrent or past medical history | |||
Hematologic diseases | 23 | 106 | <0.001 |
Dermatogic diseases | 9 | 0 | |
Renal diseases | 9 | 0 | |
Ophthalmopathy | 6 | 0 | |
Diseases of respiratory system | 5 | 0 | |
Others | 42 | 0 | |
Affected | |||
Unilateral | 15 | - | - |
Bilateral | 79 | - | |
Steroid treatment | |||
Mouth medication | 74 | 89 | 0.06 |
Intravenous injection | 36 | 71 | |
Steroid dose | |||
Large (>400 mg/d) | 34 | 60 | 0.12 |
Middle (>100 mg/d & < 400 mg/d) | 52 | 40 | |
Small | 8 | 6 | |
Days of steroid treatment | |||
Median (Range) | 360 (7–9490) | 810 (4–79934) | 0.10 |
Mean | 1140.34 ± 2014.037 | 2631.54 ± 8610.278 |